154 results on '"West, C.M.L."'
Search Results
2. Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity
3. Gene Expression Signatures as Biomarkers of Tumour Hypoxia
4. Prostate Cancer Patients with a High Polygenic Risk of Rheumatoid Arthritis have Increased Radiotherapy Toxicity
5. Time to Rethink Commercialisation: Spin out or Lose out?
6. The Prognostic Significance of the Biomarker p16 in Oropharyngeal Squamous Cell Carcinoma
7. PD-0163 Feasibility of Image-Based Data Mining in Breast Radiotherapy
8. Lack of Prognostic Effect of Carbonic Anhydrase-9, Hypoxia Inducible Factor-1α and Bcl-2 in 286 Patients with Early Squamous Cell Carcinoma of the Glottic Larynx Treated with Radiotherapy
9. A Comparison of Radiation Toxicity Outcomes in Patients With and Without Autoimmune Diagnoses on the REQUITE Study
10. Use of Angiotensin Converting Enzyme Inhibitors and Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer
11. Proteomic Profiling of Hypoxia-Induced Changes in Cell-Derived Extracellular Matrix From Bladder Cancer Cell Lines
12. Managing RT Schedules of Early-Stage Breast Cancer Patients with a Genetic-Dosimetric Validated Model for Late Fibrosis
13. Genetic Susceptibility and Predictive Assays
14. Do Polygenic Risk Scores For Cancer Susceptibility Associate With Risk Of Radiotherapy Toxicity?
15. The Largest Transcriptomic Resource for Radiotherapy-treated High-risk Prostate Cancer
16. Genome wide association study of acute radiation toxicity and quality of life in breast cancer patients – results from the REQUITE cohort study
17. Head and neck cancer - Part 2: treatment and prognostic factors
18. Requite: Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality-of-Life in Cancer Survivors
19. Predicting Prostate Radiotherapy Toxicity in a Phase III Trial Using Clinical/Dosimetric Variables in Logistic Regression and Random Forest Models
20. Requite Prostate Cohort: Validating Clinical/Dosimetric/Genetic Risk Factors for Late Urinary Toxicity
21. RAPPER — A Success Story for Collaborative Translational Radiotherapy Research
22. Evaluation of a Novel Atlas to Reduce Variability of Contouring Masticatory Muscles in Head and Neck Cancer Patients
23. Meta-Analysis of Genome-Wide Association Studies (GWAS) of Late Toxicity in 3,874 Men Treated with Radiation for Prostate Cancer
24. SURVIVING FRACTION AT 2 Gy VERSUS CONTROL OF HUMAN CERVICAL CARCINOMA - UPDATE OF THE MANCHESTER STUDY
25. SURVIVING FRACTION AT 2 GY DETERMINATIONS FOR HUMAN TUMOURS - UPDATE OF THE MANCHESTER STUDY
26. Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix
27. PO-0836: A hypoxia related gene signature is independently prognostic in multiple soft tissue sarcoma cohorts
28. OC-0267: Technical and biological validation of hypoxia PET imaging using [18F]fluroazomycin (FAZA) in NSCLC
29. Hypoxia Gene Expression Signature Independently Predicts Prognosis for Prostate Cancer Patients
30. Contribution of Common SNPs to Variability in Late Radiation Therapy Toxicity in Prostate Cancer
31. Molecular Subtyping of Muscle-Invasive Bladder Cancer Predicts Benefit of Hypoxia-Targeting Therapy
32. Weekly Integral Dose and Use of Lipid Lowering Drugs Are Associated With Worsening of Functional Outcomes in Prostate Cancer Patients Treated With IMRT
33. Vortex Trial: A Randomized Controlled Multicenter Phase 3 Trial of Volume of Postoperative Radiation Therapy Given to Adult Patients With Extremity Soft Tissue Sarcoma (STS)
34. Toward a Data Mining Approach for Risk Stratification in Prostate Cancer
35. A Higher Whole-Pelvic Integral Dose Is Associated With Worsening Fatigue and Functional Outcome in Prostate Cancer Patients Treated With Intensity Modulated Radiation Therapy
36. Biomarkers and Imaging for Precision Radiotherapy
37. EP-1822: The Radiogenomics Consortium (RGC)
38. RAPPER: The Radiogenomics of Radiation Toxicity
39. Head and neck cancer-Part 2: Treatment and prognostic factors
40. Head and neck cancer-Part 1: Epidemiology, presentation, and preservation
41. 116 A validation study of 68 single nucleotide polymorphisms which have been associated with radiation toxicity: preliminary results of the RAPPER study
42. Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a review
43. The Genomics Revolution and Radiotherapy
44. Radiosensitivity, Radiogenomics & RAPPER
45. Radiosensitivity, Radiogenomics and RAPPER
46. Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation
47. Late Radiation Morbidity in a Patient with Carcinoma of the Cervix
48. Short Report: A Morbidity Scoring System for Clinical Oncology Practice: Questionnaires produced from the LENT SOMA scoring system
49. Magnetic resonance perfusion imaging correlates with tumour oxygenation but not angiogenesis in carcinoma of the cervix
50. DNA damage assays predict normal tissue radiosensitivity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.